Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca FDA vote worth potentially US$500mln annual peak sales
10:45am, Tuesday, 02'nd May 2023
AstraZeneca PLC (LSE:AZN) forecasts for its major Lynparza drug are expected to be trimmed following an advisory vote against full approval in the US. In a US Food & Drug Administration advisory c
AstraZeneca disappointed by US panel recommendation for prostate cancer drug
03:59am, Tuesday, 02'nd May 2023
AstraZeneca PLC (LSE:AZN) has suffered a setback in its bid to deploy a key drug broadly in prostate cancer, with an influential US panel calling for a limit on its use. The Oncologic Drugs Advisory C
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
12:56pm, Thursday, 27'th Apr 2023
AstraZeneca (AZN) beats first-quarter estimates for earnings while missing the same for sales. The company reaffirms its 2023 guidance.
AstraZeneca's Q1 beat adds £4bn to the value of the drug giant
03:26am, Thursday, 27'th Apr 2023
Just over £4bn was added to the value of AstraZeneca PLC, whose shares opened 2.25% higher after the company reported better-than-expected first-quarter profit and revenue. Adjusted earnings of $1.
7 Low-Risk Stocks to Buy if You Only Want to Beat Inflation
06:29pm, Wednesday, 26'th Apr 2023
If you're looking for some low-risk stocks for inflation-proofing, investing in historically stable companies with robust cash flows and dividends is the best bet right now. A recession is on the card
AstraZeneca in uncharted waters as shares rocket higher
10:02am, Tuesday, 25'th Apr 2023
AstraZeneca delivers its first-quarter results Thursday on a hot streak. Shares have risen 15% in a month consolidating its position as the UK's largest company and no doubt pleasingly for boss Pascal
GSK minds the gap as AstraZeneca streaks ahead
08:37am, Tuesday, 25'th Apr 2023
GSK's first quarter should see the UK pharma in decent shape operationally says analysts though the ongoing legal battle over Zantac compensation will remain the main influence on the share price unti
Big Pharma earnings bonanza could shape sector going forward: PREVIEW
04:16pm, Monday, 24'th Apr 2023
When the opening bell rings on Thursday, a quintet of Big Pharma players will have just reported earnings, giving investors a picture of how the sector fared to start 2023. Eli Lily and Company, Me
AstraZeneca is now bigger than Pfizer, but what's the secret of CEO Soriot's success?
09:41am, Monday, 24'th Apr 2023
Investors, even the big and sophisticated ones, can often get it wrong due to short-termism driving their decisions. However, independent directors of a company can save them from making rash calls by
AstraZeneca overtakes former takeover rival Pfizer
05:43am, Monday, 24'th Apr 2023
British pharma giant AstraZeneca PLC (LSE:AZN) has overtaken US counterpart Pfizer plc in terms of market capitalisation in the days leading up to the former's quarterly earnings call on Thursday. FT
Mineralys: New IPO And A Leader In The Hypertension Drug Development Space
03:17pm, Friday, 21'st Apr 2023
Mineralys: New IPO And A Leader In The Hypertension Drug Development Space.
AstraZeneca results arrive with focus on drug trials, while GSK still faces Zantac overhang
01:23pm, Friday, 21'st Apr 2023
The FTSE 100's biggest company reports next week, AstraZeneca PLC (LSE:AZN) stepping up with a first-quarter trading update on Thursday, preceded by a day by its former close rival GSK PLC (LSE:GSK, N
Could This Rare-Disease Drug Candidate Become a Blockbuster?
09:15am, Wednesday, 19'th Apr 2023
AstraZeneca and Ionis recently shared promising phase 3 clinical trials for eplontersen. If approved, the drug candidate could top $1 billion in annual sales -- split between the two companies.
Astrazeneca (AZN) is a Top Dividend Stock Right Now: Should You Buy?
12:56pm, Monday, 17'th Apr 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes?
3 Healthcare Dividend Payers With Big Price Growth
07:11am, Friday, 14'th Apr 2023
You don't see financial TV channels dedicated to minute-by-minute coverage of dividend yield or increases, but for investors in companies like Sanofi (NASDAQ: SNY), AstraZeneca plc (NASDAQ: AZN), and
